Total Synthesis of (±)-Quinagolide: A Potent D₂ Receptor Agonist for the Treatment of Hyperprolactinemia.

ABSTRACT: A potent dopamine (D₂) receptor agonist (±)-quinagolide, which is used for the treatment of hyperprolactinemia, was synthesized using the ring closing metathesis (RCM) approach from meta-hydroxybenzaldehyde as the starting material. The key features of this synthesis are pyrolytic elimination, late-stage expedient synthesis of functionalized trans-fused tetrahydropyridine-3-carboxylates from olefin 6, via conjugate addition-elimination upon acetate 11, followed by RCM and phenyliodine bis(trifluoroacetate) (PIFA)-mediated Hofmann rearrangement of piperidine-3-carboxamide, which enables the synthesis of 3-aminopiperidine skeleton of quinagolide. For the total synthesis of natural products such as ergot alkaloids, late-stage synthesis of functionalized trans-f

SUBMITTER: Chavan SP 

PROVIDER: S-EPMC6648496 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature